McKesson Corporation (FRA:MCK)

Market Cap	77.01B
Revenue (ttm)	332.19B
Net Income (ttm)	3.05B
Shares Out	n/a
EPS (ttm)	23.80
PE Ratio	25.26
Forward PE	18.59
Dividend	2.57 (0.42%)
Ex-Dividend Date	Mar 3, 2025

Volume	n/a
Average Volume	11
Open	615.60
Previous Close	617.60
Day's Range	615.60 - 616.00
52-Week Range	427.70 - 644.20
Beta	n/a
RSI	48.72
Earnings Date	May 8, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1833
• Employees: 46,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD